関連する実験動画

Updated: Jul 14, 2026

Microinjection Method for Anopheles gambiae Embryos
05:39

Microinjection Method for Anopheles gambiae Embryos

Published on: July 7, 2021

5.2K

リエクティブ・フォーカル・インターベンションによるマラリア感染の減少

Manuel W Hetzel1, Nakul Chitnis1

  • 1Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland; University of Basel, Basel, Switzerland.

Lancet (London, England)
|April 27, 2020
PubMed
まとめ

No abstract available in PubMed .

さらに関連する動画

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.5K
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

460

関連する実験動画

Last Updated: Jul 14, 2026

Microinjection Method for Anopheles gambiae Embryos
05:39

Microinjection Method for Anopheles gambiae Embryos

Published on: July 7, 2021

5.2K
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.5K
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

460

関連する概念動画

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

Modelling the impact of larviciding as a supplementary malaria vector control intervention in rural south-eastern Tanzania: A district-level simulation study.

PloS one·2026

Correction: A matter of timing: Biting by malaria-infected Anopheles mosquitoes and the use of interventions during the night in rural south-eastern Tanzania.

PLOS global public health·2026

Modelling the effect of long-lasting insecticidal nets on malaria transmission dynamics in Kebbi State, Nigeria.

Infectious Disease Modelling·2026

Cascades of effectiveness of next-generation insecticide-treated nets against malaria, from entomological trials to real-life conditions.

Nature communications·2025

Immunity can impose a reproduction-survival tradeoff on human malaria parasites.

Evolution; international journal of organic evolution·2025

Determinants of locally acquired malaria infections in Zanzibar: a cross-sectional study.

Malaria journal·2025

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Knowledge and Awareness of HPV, the HPV Vaccine, and Cervical Cancer Among Women From a Brazilian Community: A Community-Based Cross-Sectional Study.

Health science reports·2026

Improving fidelity of implementation of self-administered pulse oximetry and remote patient monitoring in Honduras during the COVID-19 pandemic.

Frontiers in medicine·2026

Preventive Measures and Crowd Management Strategies to Mitigate the Risk of Stampedes in Public Gatherings: A Systematic Review.

Public health reviews·2026

From awareness to action: a comparative study of family medical history and preventive health behaviors in Saudi Arabia and Syria.

Frontiers in public health·2026

Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.

Frontiers in public health·2026

Follow-Up and Outcomes After Thermal Ablation Treatment Among HIV-Infected Women From Resource-Limited Countries With Positive HPV-Based Screening: Results of the AIMA-CC Cohort (ANRS 12375).

International journal of cancer·2026
関連記事をすべて見る
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
Jove
Visualize
お問い合わせ